Using MR-proADM to predict complications after kidney and liver transplants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the sensitivity and specificity of MR-proADM levels as an early, non-invasive biomarker for diagnosing delayed graft function (DGF) and acute rejection (AR) in kidney and liver transplant recipients. By measuring MR-proADM levels pre-operatively and post-operatively, the study will develop a predictive model using machine learning to identify patients at risk for these complications. The goal is to improve early diagnosis and management of post-transplant complications, ultimately enhancing patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Kidney transplant recipient at our Institution
* Liver transplant recipient at our Institution

Exclusion Criteria:

* Re-transplantation
* Dual kidney transplantation
* Combined transplant (kidney-liver, kidney-pancreas)
* Autoimmune disease as indication to transplant

Where it's running

• University of Rome Tor Vergata
  Rome, Italy Recruiting

Study contacts

• Principal investigator: Roberta Angelico, PhD FEBS — University of Rome Tor Vergata
• Study coordinator: Roberta Angelico, PhD FEBS
• Email: roberta.angelico@med.uniroma2.it
• Phone: 0620908294

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Doctor counseling plus smartphone apps to support healthy eating and activity after liver or kidney transplant

  This program tries whether doctor-delivered lifestyle counseling combined with two smartphone apps can help people aged 60 and older who had a liver or kidney transplant eat healthier and be more active.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, BO · NCT07305012

• Long-term health of children born to mothers who had a solid organ transplant

  This project will look for long-term heart, kidney, and immune system problems in people aged 16 and older who were born to mothers who had a kidney, liver, pancreas, heart, or lung transplant.

  Recruiting University Medical Center Groningen · Groningen, Provincie Groningen · NCT07291258

• Cardiovascular health in children and young adults with chronic conditions

  This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.

  Recruiting Semmelweis University · Budapest and 2 other locations · NCT07086989

• Omnisol-preserved kidneys before transplant (hypothermic machine perfusion)

  This study tests whether using Omnisol during hypothermic machine perfusion before kidney transplant can improve early graft function compared with standard preservation.

  Recruiting Vivalyx GmbH · Rotterdam · NCT07792317

• Expanding HIV-positive donor livers for HIV-positive recipients

  This study tests whether liver transplants from HIV-positive donors to HIV-positive recipients are safe regarding opportunistic infections and cancer.

  Recruiting at 2 sites National Institute of Allergy and Infectious Diseases (NIAID) · Baltimore, Maryland and 1 other locations · NCT07778459

• How Propofol and Sevoflurane Affect miRNA in Living Kidney Donors

  This study tests whether using propofol or sevoflurane during donor nephrectomy changes levels of miRNAs in living kidney donors.

  Recruiting University of Gaziantep · Gaziantep, Sahinbey · NCT07760402

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.